Author Credential Error In: Bleeding and Stroke Risk in a Real-World Prospective Primary Prevention Cohort of Patients With Atrial Fibrillation

Chest - United States
doi 10.1378/chest.13-1309
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies

Frontiers in Medicine
Medicine
2020English

Atrial Fibrillation and Stroke Risk Prevention in Real-Life Clinical Practice

Thrombosis and Haemostasis
Hematology
2009English

Risk Factors and Prevention of Dabigatran-Related Gastrointestinal Bleeding in Patients With Atrial Fibrillation

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2017English

Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI

New England Journal of Medicine
Medicine
2016English

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

Stroke Prevention in Atrial Fibrillation

Journal of Atrial Fibrillation
Cardiovascular MedicineCardiology
2010English

Stroke Prevention in Atrial Fibrillation

International Journal of Arrhythmia
2017English

Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2012English

Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy